{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:17:26Z","timestamp":1790194646287,"version":"4.1.0"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"vor","delay-in-days":2211,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1093\/annonc\/mdt313","type":"journal-article","created":{"date-parts":[[2013,10,16]],"date-time":"2013-10-16T14:26:35Z","timestamp":1381933595000},"page":"viii83-viii95","source":"Crossref","is-referenced-by-count":40,"special_numbering":"S8","title":["Hereditary ovarian and breast cancer: what have we learned?"],"prefix":"10.1016","volume":"24","author":[{"given":"H.T.","family":"Lynch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Casey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdt313_bb0010","unstructured":"J Ferlay HR Shin F Bray. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet] Lyon, France: International Agency for Research on Cancer 2010;2.0. Available at http:\/\/www-dep.iarc.fr\/. (30 August 2012, date last accessed)."},{"key":"10.1093\/annonc\/mdt313_bb0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"10.1093\/annonc\/mdt313_bb0020","first-page":"255","article-title":"Ovarian surface epithelium: biology, endocrinology, and pathology","volume":"22","author":"Auersperg","year":"2001","journal-title":"Endocr Rev"},{"key":"10.1093\/annonc\/mdt313_bb0025","series-title":"Principles and Practice of Gynecologic Oncology","first-page":"903","article-title":"Epithelial ovarian cancer","author":"Ozols","year":"2005"},{"key":"10.1093\/annonc\/mdt313_bb0030","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10689-004-9554-y","article-title":"Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations","volume":"3","author":"Casey","year":"2004","journal-title":"Fam Cancer"},{"key":"10.1093\/annonc\/mdt313_bb0035","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ygyno.2005.01.039","article-title":"Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations","volume":"97","author":"Casey","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mdt313_bb0040","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.molonc.2009.02.004","article-title":"Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management","volume":"3","author":"Lynch","year":"2009","journal-title":"Mol Oncol"},{"issue":"Suppl 1","key":"10.1093\/annonc\/mdt313_bb0045","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0020-7292(03)90116-0","article-title":"Carcinoma of the corpus uteri","volume":"83","author":"Creasman","year":"2003","journal-title":"Int J Gynaecol Obstet"},{"issue":"Suppl1","key":"10.1093\/annonc\/mdt313_bb0050","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0020-7292(03)90117-2","article-title":"Carcinoma of the Fallopian tube","volume":"83","author":"Heintz","year":"2003","journal-title":"Int J Gynaecol Obstet"},{"issue":"Suppl 1","key":"10.1093\/annonc\/mdt313_bb0055","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0020-7292(03)90118-4","article-title":"Carcinoma of the ovary","volume":"83","author":"Heintz","year":"2003","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1093\/annonc\/mdt313_bb0060","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/01.AOG.0000228959.30577.13","article-title":"Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations","volume":"108","author":"Schmeler","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1093\/annonc\/mdt313_bb0065","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1056\/NEJMoa052627","article-title":"Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome","volume":"354","author":"Schmeler","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdt313_bb0070","first-page":"103","article-title":"Cancer risk estimates for family members of a population-based family registry for breast and ovarian cancer","volume":"9","author":"Ziogas","year":"2000","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1093\/annonc\/mdt313_bb0075","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1158\/1078-0432.CCR-07-4806","article-title":"BRCA1 And BRCA2 mutation prevalence and clinical characteristics of a population-based series of ovarian cancer cases from Denmark","volume":"14","author":"Soegaard","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mdt313_bb0080","first-page":"644","article-title":"Carcinoma of the breast and ovary in three families","volume":"133","author":"Lynch","year":"1971","journal-title":"Surg Gynecol Obstet"},{"key":"10.1093\/annonc\/mdt313_bb0085","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1001\/jama.1972.03210130023005","article-title":"Tumor variation in families with breast cancer","volume":"222","author":"Lynch","year":"1972","journal-title":"JAMA"},{"key":"10.1093\/annonc\/mdt313_bb0090","first-page":"717","article-title":"Familial association of carcinoma of the breast and ovary","volume":"138","author":"Lynch","year":"1974","journal-title":"Surg Gynecol Obstet"},{"key":"10.1093\/annonc\/mdt313_bb0095","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1126\/science.2270482","article-title":"Linkage of early-onset breast cancer to chromosome 17q21","volume":"250","author":"Hall","year":"1990","journal-title":"Science"},{"key":"10.1093\/annonc\/mdt313_bb0100","first-page":"82","article-title":"Familial breast-ovarian cancer locus on chromosome 17q12-q23","volume":"388","author":"Narod","year":"1991","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdt313_bb0105","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","article-title":"A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1","volume":"266","author":"Miki","year":"1994","journal-title":"Science"},{"key":"10.1093\/annonc\/mdt313_bb0110","unstructured":"National Center for Biotechnology Information2008Gene National Library of Science\/National Institutes of Health 2008. Available at: URL http:\/\/www.ncbi.nlm.nih.gov\/gene. (13 November 2012, date last accessed)."},{"key":"10.1093\/annonc\/mdt313_bb0115","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1126\/science.8091231","article-title":"Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12\u201313","volume":"265","author":"Wooster","year":"1994","journal-title":"Science"},{"key":"10.1093\/annonc\/mdt313_bb0120","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/378789a0","article-title":"Identification of the breast cancer susceptibility gene BRCA2","volume":"378","author":"Wooster","year":"1995","journal-title":"Nature"},{"key":"10.1093\/annonc\/mdt313_bb0125","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","article-title":"Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families","volume":"62","author":"Ford","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1093\/annonc\/mdt313_bb0130","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10689-012-9518-6","article-title":"Adequacy of family history taking in ovarian cancer patients: a population-based study","volume":"11","author":"van Altena","year":"2012","journal-title":"Fam Cancer"},{"key":"10.1093\/annonc\/mdt313_bb0135","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s10689-012-9519-5","article-title":"Limited significance of family history for presence of BRCA1 gene mutation in polish breast and ovarian cancer cases","volume":"11","author":"Brozek","year":"2012","journal-title":"Fam Cancer"},{"key":"10.1093\/annonc\/mdt313_bb0140","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/archinte.1966.03870080050009","article-title":"Hereditary factors in cancer: study of two large midwestern kindreds","volume":"117","author":"Lynch","year":"1966","journal-title":"Arch Intern Med"},{"key":"10.1093\/annonc\/mdt313_bb0145","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0016-5085(19)34179-4","article-title":"Heredity and adenocarcinoma of the colon","volume":"53","author":"Lynch","year":"1967","journal-title":"Gastroenterology"},{"key":"10.1093\/annonc\/mdt313_bb0150","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.0.CO;2-L","article-title":"Cancer risk in mutation carriers of DNA-mismatch-repair genes","volume":"81","author":"Aarnio","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/mdt313_bb0155","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/sj.ejhg.5201584","article-title":"Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications","volume":"14","author":"Lynch","year":"2006","journal-title":"Eur J Hum Genet"},{"key":"10.1093\/annonc\/mdt313_bb0160","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10689-007-9165-5","article-title":"Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management","volume":"7","author":"Lynch","year":"2008","journal-title":"Fam Cancer"},{"key":"10.1093\/annonc\/mdt313_bb0165","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/BF02586773","article-title":"The cancer-family syndrome: a pragmatic basis for syndrome identification","volume":"22","author":"Lynch","year":"1979","journal-title":"Dis Colon Rectum"},{"key":"10.1093\/annonc\/mdt313_bb0170","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3109\/00365529709025102","article-title":"Hereditary non-polyposis colorectal cancer: clinical features and survival: results from the Danish HNPCC Register","volume":"32","author":"Myrhoj","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"10.1093\/annonc\/mdt313_bb0175","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/hmg\/6.1.105","article-title":"Cancer risk associated with germline DNA mismatch repair gene mutations","volume":"6","author":"Dunlop","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1093\/annonc\/mdt313_bb0180","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/jmg.2004.024299","article-title":"Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment","volume":"42","author":"Quehenberger","year":"2005","journal-title":"J Med Genet"},{"key":"10.1093\/annonc\/mdt313_bb0185","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1200\/JCO.2001.19.20.4074","article-title":"MSH2 Mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families","volume":"19","author":"Vasen","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdt313_bb0190","first-page":"146","article-title":"Exome-sequencing takes centre stage in cancer profiling","volume":"459","author":"Maher","year":"2009","journal-title":"Nature"},{"key":"10.1093\/annonc\/mdt313_bb0195","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nbt.1523","article-title":"Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing","volume":"27","author":"Gnirke","year":"2009","journal-title":"Nat Biotechnol"},{"key":"10.1093\/annonc\/mdt313_bb0200","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nature08250","article-title":"Targeted capture and massively parallel sequencing of 12 human exomes","volume":"461","author":"Ng","year":"2009","journal-title":"Nature"},{"key":"10.1093\/annonc\/mdt313_bb0205","doi-asserted-by":"crossref","first-page":"19096","DOI":"10.1073\/pnas.0910672106","article-title":"Genetic diagnosis by whole exome capture and massively parallel DNA sequencing","volume":"106","author":"Choi","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1093\/annonc\/mdt313_bb0210","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/modpathol.2012.62","article-title":"Gene discovery in familial cancer syndromes by exome sequencing: prospects for the elucidation of familial colorectal cancer type X","volume":"25","author":"Ku","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1093\/annonc\/mdt313_bb0215","doi-asserted-by":"crossref","first-page":"5792","DOI":"10.1158\/0008-5472.CAN-11-0773","article-title":"Modification of BRCA1-associated breast and ovarian cancer risk by BRCA1-interacting genes","volume":"71","author":"Rebbeck","year":"2011","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdt313_bb0220","doi-asserted-by":"crossref","first-page":"5801","DOI":"10.1158\/0008-5472.CAN-09-0625","article-title":"Modification of ovarian cancer risk by BRCA1\/2-interacting genes in a multicenter cohort of BRCA1\/2 mutation carriers","volume":"69","author":"Rebbeck","year":"2009","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdt313_bb0225","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/ng.669","article-title":"A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population","volume":"42","author":"Antoniou","year":"2010","journal-title":"Nat Genet"},{"key":"10.1093\/annonc\/mdt313_bb0230","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1086\/522611","article-title":"RAD51 135G>C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies","volume":"81","author":"Antoniou","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1093\/annonc\/mdt313_bb0235","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/ng.569","article-title":"Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptiblity gene","volume":"42","author":"Meindl","year":"2010","journal-title":"Nat Genet"},{"key":"10.1093\/annonc\/mdt313_bb0240","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/ng.893","article-title":"Germline mutations in RAD51D confer susceptibility to ovarian cancer","volume":"43","author":"Loveday","year":"2011","journal-title":"Nat Genet"},{"key":"10.1093\/annonc\/mdt313_bb0245","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/ng1295-428","article-title":"Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype\u2013phenotype correlation","volume":"11","author":"Gayther","year":"1995","journal-title":"Nat Genet"},{"key":"10.1093\/annonc\/mdt313_bb0250","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/ng0197-103","article-title":"Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene","volume":"15","author":"Gayther","year":"1997","journal-title":"Nat Genet"},{"key":"10.1093\/annonc\/mdt313_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/B:FAME.0000026816.32400.45","article-title":"Cancer variation associated with the position of the mutation in the BRCA2 gene","volume":"3","author":"Lubinski","year":"2004","journal-title":"Fam Cancer"},{"key":"10.1093\/annonc\/mdt313_bb0260","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1086\/318181","article-title":"Variation in cancer risks, by mutation position, in BRCA2 mutation carriers","volume":"68","author":"Thompson","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1093\/annonc\/mdt313_bb0265","first-page":"329","article-title":"Variation in BRCA1 cancer risks by mutation position","volume":"11","author":"Thompson","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1093\/annonc\/mdt313_bb0270","doi-asserted-by":"crossref","first-page":"900","DOI":"10.7326\/0003-4819-157-11-201212040-00539","article-title":"on behalf of the U.S.Preventive Services Task Force. Screening for ovarian cancer: US Preventive Services Task Force reaffirmation recommendation statement","volume":"157","author":"Moyer","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1093\/annonc\/mdt313_bb0275","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/sj.bjc.6603015","article-title":"Surveillance of women at high risk for hereditary ovarian cancer is inefficient","volume":"94","author":"Oei","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdt313_bb0280","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jama.296.2.185","article-title":"Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation","volume":"296","author":"Finch","year":"2006","journal-title":"JAMA"},{"key":"10.1093\/annonc\/mdt313_bb0285","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1200\/JCO.2007.13.9626","article-title":"Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study","volume":"26","author":"Kauff","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdt313_bb0290","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1200\/JCO.2004.00.7138","article-title":"Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study","volume":"23","author":"Eisen","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdt313_bb0295","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","article-title":"Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers","volume":"101","author":"Rebbeck","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdt313_bb0300","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1002\/cncr.25820","article-title":"Satisfaction with ovarian carcinoma risk-reduction strategies among women at high risk for breast and ovarian carcinoma","volume":"117","author":"Westin","year":"2011","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdt313_bb0305","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.soc.2009.07.001","article-title":"Genetic counseling for hereditary colorectal cancer: ethical, legal, and psychosocial issues","volume":"18","author":"Aronson","year":"2009","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1093\/annonc\/mdt313_bb0310","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10350-003-0034-5","article-title":"Acceptance of and attitude toward genetic testing for hereditary nonpolyposis colorectal cancer: a comparison of participants and nonparticipants in genetic counseling","volume":"47","author":"Keller","year":"2004","journal-title":"Dis Colon Rectum"},{"key":"10.1093\/annonc\/mdt313_bb0315","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1001\/jama.281.17.1618","article-title":"Genetic testing in families with hereditary nonpolyposis colon cancer","volume":"281","author":"Lerman","year":"1999","journal-title":"JAMA"},{"key":"10.1093\/annonc\/mdt313_bb0320","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1136\/jmg.2007.051581","article-title":"Direct contact in inviting high-risk members of hereditary colon cancer families to genetic counselling and DNA testing","volume":"44","author":"Aktan-Collan","year":"2007","journal-title":"J Med Genet"},{"key":"10.1093\/annonc\/mdt313_bb0325","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10689-004-7992-1","article-title":"Informing one's family about a genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a retrospective exploratory study","volume":"4","author":"Mesters","year":"2005","journal-title":"Fam Cancer"},{"key":"10.1093\/annonc\/mdt313_bb0330","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0016-5085(00)70168-5","article-title":"Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer","volume":"118","author":"J\u00e4rvinen","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1093\/annonc\/mdt313_bb0335","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1053\/j.gastro.2005.11.032","article-title":"Decrease in mortality in Lynch syndrome families because of surveillance","volume":"130","author":"de Jong","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1093\/annonc\/mdt313_bb0340","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/(SICI)1097-0215(20000120)89:1<44::AID-IJC8>3.0.CO;2-3","article-title":"Predictive genetic testing for hereditary non-polyposis colorectal cancer: uptake and long-term satisfaction","volume":"89","author":"Aktan-Collan","year":"2000","journal-title":"Int J Cancer (Pred Oncol)"},{"key":"10.1093\/annonc\/mdt313_bb0345","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/ijc.1372","article-title":"Psychological consequences of predictive genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a prospective follow-up study","volume":"93","author":"Aktan-Collan","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/mdt313_bb0350","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1136\/jmg.38.11.787","article-title":"Comprehension of cancer risk one and 12 months after predictive genetic testing for hereditary non-polyposis colorectal cancer","volume":"38","author":"Aktan-Collan","year":"2001","journal-title":"J Med Genet"},{"key":"10.1093\/annonc\/mdt313_bb0355","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1399-0004.2004.00339.x","article-title":"Psychological impact of genetic testing for hereditary non-polyposis colorectal cancer","volume":"66","author":"Meiser","year":"2004","journal-title":"Clin Genet"},{"key":"10.1093\/annonc\/mdt313_bb0360","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1089\/gte.2005.9.54","article-title":"Predictive testing for hereditary nonpolyposis colorectal cancer: subjective perception regarding colorectal and endometrial cancer, distress, and health-related behavior at one year post-test","volume":"9","author":"Claes","year":"2005","journal-title":"Genet Test"},{"key":"10.1093\/annonc\/mdt313_bb0365","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1200\/JCO.2005.07.102","article-title":"Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer","volume":"23","author":"Gritz","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdt313_bb0370","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/jama.292.12.1469","article-title":"The \u2018duty to warn\u2019 a patient's family members about hereditary disease risks","volume":"292","author":"Offit","year":"2004","journal-title":"JAMA"},{"key":"10.1093\/annonc\/mdt313_bb0375","unstructured":"Tarasoff v the Regents of the University of California, 551 P 2d 334 (Cal 1976)."},{"key":"10.1093\/annonc\/mdt313_bb0380","unstructured":"Safer v. Estate of Pack, 677 A.2d 1188 (NJ App), appeal denied, 683 A2d1163 (NJ 1996)."},{"key":"10.1093\/annonc\/mdt313_bb0385","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/sj.ejhg.5201373","article-title":"Cascade screening: whose information is it anyway?","volume":"13","author":"de Wert","year":"2005","journal-title":"Eur J Hum Genet"},{"key":"10.1093\/annonc\/mdt313_bb0390","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/sj.ejhg.5201360","article-title":"Cascade testing in familial hypercholesterolaemia: how should family members be contacted?","volume":"13","author":"Newson","year":"2005","journal-title":"Eur J Hum Genet"},{"key":"10.1093\/annonc\/mdt313_bb0395","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10689-005-2581-5","article-title":"Guidelines for disclosing genetic information to family members: from development to use","volume":"5","author":"Godard","year":"2006","journal-title":"Fam Cancer"},{"key":"10.1093\/annonc\/mdt313_bb0400","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/14636770600603485","article-title":"Genetics and prevention: a policy in the making","volume":"25","author":"Svendsen","year":"2006","journal-title":"New Genet Soc"},{"key":"10.1093\/annonc\/mdt313_bb0405","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2354.2006.00660.x","article-title":"When legal worlds collide: from research to treatment in hereditary cancer prevention","volume":"15","author":"Tupasela","year":"2006","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1093\/annonc\/mdt313_bb0410","unstructured":"H K\u00e4\u00e4ri\u00e4inen E Rantanen M Hietala. Summary of the Guidelines for Genetic Counselling, 2006 Eurogentest 2006 URL http:\/\/eurogentest.org\/web\/files\/public\/unit3\/summaryofguidelinesMay06.pdf. (13 November 2012, date last accessed)."},{"key":"10.1093\/annonc\/mdt313_bb0415","unstructured":"Council on Ethical and Judicial Affairs of the American Medical AssociationOpinion 2.131\u2014Disclosure of Familial Risk in Genetic Testing American Medical Association 2003; http:\/\/www.ama-assn.org\/ama\/pub\/physician-resources\/medical-ethics\/code-medical-ethics\/opinion2131.page. (13 November 2012, date last accessed)."},{"key":"10.1093\/annonc\/mdt313_bb0420","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1200\/JCO.2003.03.189","article-title":"American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility","volume":"21","author":"American Society of Clinical Oncology","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdt313_bb0425","unstructured":"Pate v. Threlkel, 661 So.2d 278 (1995)."},{"key":"10.1093\/annonc\/mdt313_bb0430","unstructured":"Molloy v Meier, Nos. C9\u201302\u20131821, C9-02-1837 (Minn 2004)."},{"key":"10.1093\/annonc\/mdt313_bb0435","series-title":"Screening and Counseling for Genetic Conditions: The Ethical, Social and Legal Implications of Genetics Screening, Counseling, and Education Programs","author":"President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Biobehavioral Research","year":"1998"},{"key":"10.1093\/annonc\/mdt313_bb0440","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1086\/301707","article-title":"ASHG Statement: professional disclosure of familial genetic information","volume":"62","author":"American Society of Human Genetics","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1093\/annonc\/mdt313_bb0445","series-title":"Implications for Health and Social Policy","article-title":"Assessing Genetic Risks","author":"Andrews","year":"1994"},{"key":"10.1093\/annonc\/mdt313_bb0450","series-title":"Canadian Tort Law","author":"Linden","year":"1993"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419315960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419315960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/24\/suppl_8\/viii83\/6676655\/mdt313.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T14:07:37Z","timestamp":1635775657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419315960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":89,"alternative-id":["S0923753419315960"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdt313","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}